Stereospecificity of ginsenoside Rg3 in promotion of the immune response to ovalbumin in mice

International Immunology

Volumn 24, Issue 7, 2012, Pages 465-471

  Wei, Xiaojie ^a,b   Chen, Jian ^a   Su, Fei ^a   Su, Xiaoyan ^c   Hu, Tingjun ^b   Hu, Songhua ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b GUANGXI UNIVERSITY   (China)

^c FUJIAN AGRICULTURE AND FORESTRY UNIVERSITY   (China)

Author keywords

(R) or (S) stereoisomers; Adjuvant; Ginseng; Ginsenoside Rg3; T h1 T h2

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; GINSENOSIDE RG 3; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; MESSENGER RNA; OVALBUMIN; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BLOOD SAMPLING; CONTROLLED STUDY; EPIMER; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; STEREOSPECIFICITY; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GINSENOSIDES; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; OVALBUMIN; STEREOISOMERISM; T-BOX DOMAIN PROTEINS; TRANSCRIPTIONAL ACTIVATION;

EID: 84864005465     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs043     Document Type: Article

References (49)

1. O'Hagan, D. T., MacKichan, M. L. and Singh, M. 2001. Recent developments in adjuvants for vaccines against infectious diseases. Biomol. Eng. 18:69.
2. Song, X. and Hu, S. 2009. Adjuvant activities of saponins from traditional Chinese medicinal herbs. Vaccine 27:4883.
3. Li, C. P. and Li, R. C. 1973. An introductory note to ginseng. Am. J. Chin. Med. 1:249.
4. Commission, C. P. 2010. Ren Shen (Radix et Rhizoma Ginseng). In Commission, C. P., ed., Pharmacopoeia of the People's Republic of China, Part I, p. 7. Chemical Industry Press, Beijing, China.
5. Commission, C. V. P. 2010. Ren Shen (Radix et Rhizoma Ginseng). In Commission, C. V. P., ed., Veterinary Pharmacopoeia of the People's Republic of China, Part II, p. 11. Chinese Agricultural Publishing House, Beijing, China.
6. Surh, Y. J., Na, H. K., Lee, J. Y. and Keum, Y. S. 2001. Molecular mechanisms underlying anti-tumor promoting activities of heatprocessed Panax ginseng C.A. Meyer. J. Korean. Med. Sci. 16 (suppl):S38.
7. Kowalski, R. 2007. Studies of selected plant raw materials as alternative sources of triterpenes of oleanolic and ursolic acid types. J. Agric. Food Chem. 55:656.
8. Wurglics, M., Tawab, M. A., Bahr, U., Karas, M. and Schubert-Zsilavecz, M. 2003. Degradation of ginsenosides in humans after oral administration. Drug. Metab. Dispos. 31:1065.
9. Yuan, C. S., Wu, J. A. and Osinski, J. 2002. Ginsenoside variability in American ginseng samples. Am. J. Clin. Nutr. 75:600.
10. Zhang, Q. Y., Kang, X. M. and Zhao, W. H. 2006. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma. Biochem. Bioph. Res. 342:824.
11. Yuan, C. S., Shao, Z. H., Xie, J. T. et al. 2004. Antioxidant effects of American ginseng berry extract in cardiomyocytes exposed to acute oxidant stress. Biochim Biophys Acta 1670:165.
12. Park, E. K., Choo, M. K., Han, M. J. and Kim, D. H. 2004. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int. Arch. Allergy Imm 133:113.
13. Rivera, E., Daggfeldt, A. and Hu, S. 2003. Ginseng extract in aluminium hydroxide adjuvanted vaccines improves the antibody response of pigs to porcine parvovirus and Erysipelothrix rhusiopathiae. Vet. Immunol. Immunopathol. 91:19.
14. Rivera, E., Hu, S. and Concha, C. 2003. Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants. Vaccine 21:1149.
15. Hu, S., Concha, C., Lin, F. and Waller, K. P. 2003. Adjuvant effect of ginseng extracts on the immune responses to immunisation against Staphylococcus aureus in dairy cattle. Vet. Immunol. Immunopathol. 91:29.
16. Hu, Y. L., Kong, X. F., Rui, R., Wang, D. Y. and Li, X. G. 2004. Effects of Chinese herbal medicinal ingredients on peripheral lymphocyte proliferation and serum antibody titer after vaccination in chicken. Int. Immunopharmacol. 4:975.
17. Rivera, E., Pettersson, F. E., Inganas, M., Paulie, S. and Gronvik, K. O. 2005. The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine 23:5411.
18. Hu, S., Sun, J. H. and Song, X. M. 2007. Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice. Vaccine 25:1114.
19. Chang, K. H., Jee, H. S., Lee, N. K., Park, S. H., Lee, N. W. and Paik, H. D. 2009. Optimization of the enzymatic production of 20(S)-ginsenoside Rg(3) from white ginseng extract using response surface methodology. N. Biotechnol. 26:181.
20. Kim, N. D., Kang, S. Y., Park, J. H. and Schini-Kerth, V. B. 1999. Ginsenoside Rg3 mediates endothelium-dependent relaxation in response to ginsenosides in rat aorta: role of K+ channels. Eur. J. Pharmacol. 367:41.
21. Chen, D., Cui, J. S. and Liu, X. X. 2008. Study on Hela cell apoptosis induced by 20(S)-ginsendoside Rg3 in cervical cancer. Chin. J. Lab. Diagn. 12:463.
22. Xin, Y., Ni, J. S., Wang, X. R., Shi, B., Wang, Y. H. and Wu, J. X. 2004. Inhibitory effect of 20(S)-ginsenoside Rg3 on B16 melanoma metastasis. J. Jilin Univ. 30:540.
23. Li, X., Guan, Y. S., Zhou, X. P. et al. 2005. Anticarcinogenic effect of 20(R)-ginsenoside Rg3 on induced hepatocellular carcinoma in rats. J. Sichuan Univ. 36:217.
24. Gao, S., Tang, W., Zhang, Y., Gao, J. and Ding, X. 2008. The Antifatigue Effect of 20(R)-ginsenoside Rg3 in mice by intranasally administration. Biol. Pharm. Bull. 31:2024.
25. Wang, H. and Lin, Y. 2009. Advances in anti-tumor effects of ginsenoside Rg3. Med. Rec. 15:323.
26. Larsen, S. T. and Nielsen, G. D. 2007. The adjuvant effect of di-(2-ethylhexyl) phthalate is mediated through a PPAR alpha-independent mechanism. Toxicol. Lett. 170:223.
27. Song, X. M., Zang, L. M. and Hu, S. H. 2009. Amplified immune response by ginsenoside-based nanoparticles (ginsomes). Vaccine 27:2306.
28. Livak, K. J. and Schmittgen, T. D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 25:402.
29. Ding, L. W. 2010. Investigation of ginseng markets. Mod. Chin. Med. 12:44.
30. Liu, C. X. and Xiao, P. G. 1992. Recent advances on ginseng research in China. J. Ethnopharmacol. 36:27.
31. Seong, Y. H., Shin, C. S., Kim, H. S. and Baba, A. 1995. Inhibitory effects of ginseng total saponins on glutamate-induced swelling of cultured astrocytes. Biol. Pharm. Bull. Commun. 18:1776.
32. Kitts, D. D., Wijewickreme, A. N. and Hu, C. 2000. Antioxidant properties of a North American ginseng extract. Mol. Cell. Biochem. 203:1.
33. Joo, S. S., Yoo, Y. M., Ahn, B. W. et al. 2008. Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation. Biol. Pharm. Bull. 31:1392.
34. Song, X. M., Chen, J., Sakwiwatkul, K., Li, R. and Hu, S. H. 2010. Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re. Inter. Immunol. 10:351.
35. Zhai, L. J., Li, Y. T., Wang, W. Y., Wang, Y. M. and Hu, S. H. 2011. Effect of oral administration of ginseng stem-and-leaf saponins (GSLS) on the immune responses to Newcastle disease vaccine in chickens. Vaccine 29:5007.
36. Zhai, L., Li, Y. T., Wang, W. Y. and Hu, S. H. 2011. Enhancement of humoral immune responses to inactivated Newcastle disease and avian influenza vaccines by oral administration of ginseng stemand-leaf saponins in chickens. Poul. Sci. 90:1955.
37. Li, X. and Li, L. 1991. Pharmacological changes of ginseng resulting from the processing. Zhongguo Zhong Yao Za Zhi 16:3.
38. Kwon, S. W., Han, S. B., Park, I. H., Kim, J. M., Park, M. K. and Park, J. H. 2001. Liquid chromatographic determination of less polar ginsenosides in processed ginseng. J. Chromatogr. A 921:335.
39. Lau, A. J., Seo, B. H., Woo, S. O. and Koh, H. L. 2004. Highperformance liquid chromatographic method with quantitative comparisons of whole chromatograms of raw and steamed Panax notoginseng. J. Chromatogr. A 1057:141.
40. Park, J. H., Kim, W. Y., Kim, J. M. et al. 2000. Steaming of ginseng at high temperature enhances biological activity. J. Nat. Prod. 63:1702.
41. Kang, K. S., Kim, H. Y., Yamabe, N. and Yokozawa, T. 2006. Stereospecificity in hydroxyl radical scavenging activities of four ginsenosides produced by heat processing. Bioorg. Med. Chem. Lett. 16:5028.
42. Liu, Z. H., Li, L. and Qian, F. 2009. Process optimization of ginsenoside Rg3 prepared by hydrolysing Panax Notoginseng saponins by acetic acid. Chin. J. Hosp. Pharm. 29:881.
43. Li, X., Wan, H. G., Lu, D. Q. and Wei, P. 2003. Advance of research on antitumour activity of ginsenosides. Chin. J. Bioprocess Eng. 1:13.
44. Kang, D. I., Lee, J. Y., Yang, J. Y. et al. 2005. Evidence that the tertiary structure of 20(S)-ginsenoside Rg(3) with tight hydrophobic packing near the chiral center is important for Na(+) channel regulation. Biochem. Biophys. Res. Commun. 333:1194.
45. Chung, S. H., Park, M. W. and Ha, J. 2008. 20(S)-ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK. Biol. Pharm. Bull. 31:748.
46. Mochizuki, M., Yoo, Y. C., Matsuzawa, K. et al. 1995. Inhibitory effect of tumor-metastasis in mice by saponins, ginsenoside-Rb2, 20(R)-ginsenoside-Rg3 and 20(S)-ginsenoside-Rg3, of red-ginseng. Biol. Pharm. Bull. 18:1197.
47. Li, Y. X., Qu, X. B., Zhao, Y., Song, Y., Zhang, W. and Zhao, B. 2008. Raman spectroscopy study on the structure of ginsenoside Rg3. Guang Pu Xue Yu Guang Pu Fen Xi 28:569.
48. Feldman, M. J. 2001. Cell cooperation in the antibody response. In Roitt, I., Brostoff, J. and Male, D., eds, Immunology, 6th edn. Mosby Publication, London, UK.
49. Marciani, D. J., Press, J. B., Reynolds, R. C. et al. 2000. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity. Vaccine 18:3141.